Literature DB >> 4566220

The therapy of osteogenic sarcoma: current status and thoughts for the future.

M A Friedman, S K Carter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4566220     DOI: 10.1002/jso.2930040512

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  42 in total

1.  Chemotherapy of osteosarcoma [proceedings].

Authors:  N M Bleehen
Journal:  Proc R Soc Med       Date:  1976-08

2.  Unusually long survival time after resection and irradiation of a brain metastasis from osteosarcoma.

Authors:  A Niedeggen; J Weis; R Mertens; J Röther; J Bröcheler
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

3.  Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.

Authors:  Aina He; Weixiang Qi; Yujing Huang; Yuanjue Sun; Zan Shen; Hui Zhao; Yumei Yang; Yang Yao
Journal:  Int J Clin Oncol       Date:  2012-04-26       Impact factor: 3.402

Review 4.  Current impact of adjuvant chemotherapy in resectable cancer.

Authors:  A Rossi; G Bonadonna
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 5.  Progress in the chemotherapeutic treatment of osteosarcoma.

Authors:  Ya Zhang; Jingqing Yang; Na Zhao; Cao Wang; Santosh Kamar; Yonghong Zhou; Zewei He; Jifei Yang; Bin Sun; Xiaoqian Shi; Lei Han; Zuozhang Yang
Journal:  Oncol Lett       Date:  2018-09-12       Impact factor: 2.967

6.  Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.

Authors:  J S Whelan; R C Jinks; A McTiernan; M R Sydes; J M Hook; L Trani; B Uscinska; V Bramwell; I J Lewis; M A Nooij; M van Glabbeke; R J Grimer; P C W Hogendoorn; A H M Taminiau; H Gelderblom
Journal:  Ann Oncol       Date:  2011-10-19       Impact factor: 32.976

7.  Local growth and the prognosis of osteosarcoma.

Authors:  P Wuisman; W F Enneking; A Roesner
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

Review 8.  Intercalary reconstructions after bone tumor resections: a review of treatments.

Authors:  Georgios N Panagopoulos; Andreas F Mavrogenis; Cyril Mauffrey; Jan Lesenský; Andrea Angelini; Panayiotis D Megaloikonomos; Vasilios G Igoumenou; John Papanastassiou; Olga Savvidou; Pietro Ruggieri; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-05

Review 9.  The multidisciplinary management of osteosarcoma.

Authors:  Noah Federman; Nicholas Bernthal; Fritz C Eilber; William D Tap
Journal:  Curr Treat Options Oncol       Date:  2009-02-24

10.  Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.

Authors:  Denise K Walters; Roman Muff; Bettina Langsam; Philipp Gruber; Walter Born; Bruno Fuchs
Journal:  Invest New Drugs       Date:  2007-04-26       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.